Prats E, Aisa F, Abós M D, Villavieja L, García-López F, Asenjo M J, Razola P, Banzo J
Department of Nuclear Medicine, University Teaching Hospital, Zaragoza, Spain.
J Nucl Med. 1999 Feb;40(2):296-301.
The aim of this work has been to evaluate whether a diagnostic protocol based on the joint use of mammography and 99mTc-methoxyisobutyl isonitrile (MIBI) scintimammography is capable of reducing the number of biopsies required in patients with suspected breast cancer.
We performed prone scintimammography in 90 patients with suspected breast cancer, involving 97 lesions. In all patients, the diagnosis was established by way of biopsy. On mammography, we evaluated the degree of suspicion of malignancy and the size of the lesion (smaller or larger than 1 cm in diameter).
The results of only 41 of the biopsies indicated malignancy. On mammography, 20 lesions (of which 1 was breast cancer) were considered to be of low suspicion of malignancy, 31 (of which 4 were breast cancer) as indeterminate and 46 (of which 36 were breast cancer) as high. Fourteen lesions (2 low probability, 2 indeterminate and 10 high) were smaller than 1 cm, whereas 83 (18 low probability, 29 indeterminate and 36 high) were larger. The sensitivity, specificity, positive predictive value and negative predictive value of scintimammography were 85%, 79%, 74% and 88%, respectively. Scintimammography was positive in all cases of breast cancer that initially had a low or indeterminate suspicion of malignancy according to mammography, as well as in 30 cases of breast cancer that initially were highly suspicious. Six false-negative scintimammography studies were obtained in lesions with a high suspicion of malignancy.
We propose a diagnostic protocol with a biopsy performed on lesions that have a high suspicion of malignancy as well as those with low or indeterminate suspicion that are smaller than 1 cm or with positive scintimammography results. This would have reduced the total number of biopsies performed by 34%. More importantly, there would have been a 65% reduction in number of biopsies performed in the low and indeterminate mammographic suspicion groups. All 41 cases of breast cancer would have been detected.
本研究的目的是评估基于乳腺X线摄影和99mTc-甲氧基异丁基异腈(MIBI)乳腺闪烁显像联合使用的诊断方案是否能够减少疑似乳腺癌患者所需的活检次数。
我们对90例疑似乳腺癌患者进行了俯卧位乳腺闪烁显像,共涉及97个病灶。所有患者均通过活检确诊。在乳腺X线摄影中,我们评估了恶性怀疑程度和病灶大小(直径小于或大于1 cm)。
仅41例活检结果显示为恶性。在乳腺X线摄影中,20个病灶(其中1个为乳腺癌)被认为恶性怀疑程度低,31个(其中4个为乳腺癌)为不确定,46个(其中36个为乳腺癌)为高度怀疑。14个病灶(2个低概率、2个不确定和10个高度怀疑)直径小于1 cm,而83个(18个低概率、29个不确定和36个高度怀疑)直径大于1 cm。乳腺闪烁显像的敏感性、特异性、阳性预测值和阴性预测值分别为85%、79%、74%和88%。乳腺闪烁显像在所有最初根据乳腺X线摄影恶性怀疑程度低或不确定的乳腺癌病例中均为阳性,以及在最初高度怀疑的30例乳腺癌病例中也为阳性。在高度怀疑恶性的病灶中获得了6例假阴性乳腺闪烁显像研究结果。
我们提出一种诊断方案,对高度怀疑恶性的病灶以及恶性怀疑程度低或不确定且直径小于1 cm或乳腺闪烁显像结果为阳性的病灶进行活检。这将使活检总数减少34%。更重要的是,在乳腺X线摄影恶性怀疑程度低和不确定的组中,活检次数将减少65%。所有41例乳腺癌病例均能被检测到。